http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0312547-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4c7c7b4a876986b4f7d6fd44fb7b229
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d5bb9b9a6d998b72b154ceb1895a3f5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
filingDate 2003-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af829449b873d57bdf9506c606be98fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dceea84742278179a759d7e4a909ea61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c804c5e2e8f9c5a2b4eac6b1927cabc1
publicationDate 2005-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0312547-A
titleOfInvention Viral Inhibitors
abstract "VIRAL INHIBITORS". The present invention relates to a pharmaceutical composition for the treatment or prevention of viral infections comprising as an active ingredient at least one imidazo [4,5-c] pyridine derivative having the general formula (Z): The invention also relates to: to processes for the preparation of compounds according to the invention having the general formula mentioned above and their use as a medicament or for treating or preventing viral infections.
priorityDate 2002-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425153719

Total number of triples: 32.